FDA Orange Book

Is there a generic for Atorvaliq?

Atorvaliq contains atorvastatin. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Atorvaliq (atorvastatin). The Orange Book shows its last listed patent expires June 7, 2037.

Run it in Rivvi

Map Atorvaliq and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Atorvaliq products in the Orange Book

Atorvaliq products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
suspension, oral20MG/5MLMarketed (Rx)None0None

NDA 213260, held by CMP DEVELOPMENT LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Atorvaliq patents

Patents listed for Atorvaliq
PatentExpiresCoversUse codeNDA
11654106June 7, 2037Drug productU-3612213260
11654106June 7, 2037Drug productU-3613213260
11925704June 7, 2037Drug productU-3853213260
12370136June 7, 2037Drug productNone213260
12599553June 7, 2037Drug productNone213260
12168069June 7, 2037Drug productNone213260
11369567June 7, 2037Drug productNone213260

Atorvaliq NDC codes

Questions

Is there a generic for Atorvaliq?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Atorvaliq (atorvastatin). The Orange Book shows its last listed patent expires June 7, 2037.

What is the generic name for Atorvaliq?

The active ingredient in Atorvaliq is atorvastatin, per the FDA Orange Book.

When does the Atorvaliq patent expire?

The last patent listed for Atorvaliq in the Orange Book expires June 7, 2037. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Atorvaliq and Atorvastatin

Try it on your own data today.

Free to start. Most teams are using it the same day.